Earnings History Data for Aytu BioPharma, Inc. (AYTU) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aytu BioPharma, Inc.

Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction. Aytu BioScience, Inc. is based in Englewood, Colorado.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-02-2025	AH		AYTU	Aytu BioPharma, Inc.	9.53	-0.28	0.00	-0.04	Aytu BioPharma GAAP EPS of -$0.26 beats by $0.02, revenue of $16.22M beats by $0.67M [2/12/2025 5:00 PM]	1.39	0.0 (0.00%)	1.50	0.11 (7.91%)	1.30 - 3.45	35,608	30,000	2,235
Aytu BioPharma GAAP EPS of -$0.26 beats by $0.02, revenue of $16.22M beats by $0.67M [2/12/2025 5:00 PM] Aytu BioPharma anticipates positive cash flow with ADHD growth and $2M annual cost savings [2/12/2025 6:35 PM] Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results [2025-02-12 04:03PM] Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ... [2025-02-13 08:00AM]
13-11-2024	AH		AYTU	Aytu BioPharma, Inc.	10.88	-0.20	0.00	-1.48	Aytu BioPharma GAAP EPS of -$0.20 beats by $0.14, revenue of $16.57M beats by $2.8M [11/13/2024 4:44 PM]	1.55	-0.20 (-11.17%)	1.72	-0.03 (-1.43%)	1.49 - 3.45	151,245	50,000	4,582
Aytu BioPharma GAAP EPS of -$0.20 beats by $0.14, revenue of $16.57M beats by $2.8M [11/13/2024 4:44 PM] Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results [2024-11-13 04:05PM] Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... [2024-11-14 02:16AM]
26-09-2024	AH		AYTU	Aytu BioPharma, Inc.	14.21	-0.82	0.00	0.16	Aytu BioPharma FY GAAP EPS of -$2.86 misses by $0.37, revenue of $81M misses by $0.33M [9/26/2024 4:28 PM]	2.35	-0.50 (-17.51%)	2.60	-0.25 (-8.74%)	1.66 - 3.50	226,522	20,000	9,227
Aytu BioPharma FY GAAP EPS of -$2.86 misses by $0.37, revenue of $81M misses by $0.33M [9/26/2024 4:28 PM] Aytu BioPharma files mixed offering [9/26/2024 5:08 PM] Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results [2024-09-26 04:15PM] Q4 2024 Aytu Biopharma Inc Earnings Call [2024-09-27 07:40AM]
14-02-2024	AH		AYTU	Aytu BioPharma, Inc.	16.31	-0.04	0.00	-1.31	Aytu BioScience GAAP EPS of -$0.04 beats by $0.21, revenue of $22.93M beats by $1.18M [2/14/2024 4:20 PM]	3.15	0.0 (0.00%)	3.27	0.12 (3.81%)	1.38 - 3.50	22,057	30,000	5,323
Aytu BioScience GAAP EPS of -$0.04 beats by $0.21, revenue of $22.93M beats by $1.18M [2/14/2024 4:20 PM]
27-09-2023	AH		AYTU	Aytu BioPharma, Inc.	6.12	0.16	0.00	5.00	Aytu BioScience GAAP EPS of -$0.59 beats by $0.36, revenue of $30.73M beats by $3.04M [9/27/2023 4:24 PM]	2.67	0.75 (39.06%)	1.88	-0.04 (-2.08%)	1.38 - 4.88	6,228,486	30,000	5,388
Aytu BioScience GAAP EPS of -$0.59 beats by $0.36, revenue of $30.73M beats by $3.04M [9/27/2023 4:24 PM]
11-05-2023	AH	After the close (May 11)	AYTU	Aytu BioPharma, Inc.	7.75	-1.93	0.00	-5.40	Aytu BioScience GAAP EPS of -$1.93 misses by $1.30, revenue of $22.7M misses by $5.3M [5/11/2023 4:11 PM]	1.84	-0.28 (-12.97%)	2.14	0.02 (0.94%)	1.40 - 16.19	100,867	140,000	824
Aytu BioScience GAAP EPS of -$1.93 misses by $1.30, revenue of $22.7M misses by $5.3M [5/11/2023 4:11 PM]
21-02-2023	AH	After the close (Feb 14)	AYTU	Aytu BioPharma	9.00	-1.31	0.20	0.00	Aytu BioScience GAAP EPS of -$2.15, revenue of $26.28M [2/21/2023 4:23 PM]	2.74	-0.20 (-6.80%)	3.07	0.13 (4.42%)	2.74 - 26.80	110,585	40,000	140
Aytu BioScience GAAP EPS of -$2.15, revenue of $26.28M [2/21/2023 4:23 PM]
14-11-2022	AH		AYTU	Aytu BioPharma, Inc.	9.96	-0.06	0.00	-0.33	Aytu BioScience GAAP EPS of -$0.06, revenue of $27.66M [11/14/2022 4:09 PM]	0.1955	-0.01 (-3.22%)	0.21	0.0 (1.93%)	0.15 - 2.54	1,847,788	850,000	216,240
Aytu BioScience GAAP EPS of -$0.06, revenue of $27.66M [11/14/2022 4:09 PM] Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023 [Nov-14-22 04:05PM]
27-09-2022	AH	7:20 PM ET (Sep 27)	AYTU	Aytu BioPharma, Inc.	12.00	-0.25	-0.24	-0.67	Aytu BioScience GAAP EPS of -$0.49 misses by $0.12, revenue of $27.45M beats by $1.95M [9/27/2022 4:12 PM]	0.1960	0.01 (3.16%)	0.19	0.0 (-2.58%)	0.18 - 3.06	2,234,245	1,070,000	366,183
Aytu BioScience GAAP EPS of -$0.49 misses by $0.12, revenue of $27.45M beats by $1.95M [9/27/2022 4:12 PM] Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue [Sep-27-22 04:05PM] Edited Transcript of AYTU.OQ earnings conference call or presentation 27-Sep-22 8:30pm GMT [Sep-27-22 04:30PM]
15-11-2021	AH	4:05 PM ET (Nov 15)	AYTU	Aytu BioPharma, Inc.	66.68	-0.33	0.00	-0.40	Aytu BioScience EPS misses by $0.60, misses on revenue [11/15/2021 4:18 PM]	2.20	-0.25 (-10.20%)	2.34	-0.11 (-4.49%)	2.19 - 11.76	626,757	370,000	2,219
Aytu BioScience EPS misses by $0.60, misses on revenue [11/15/2021 4:18 PM] Aytu BioPharma Reports First Quarter 2022 Financial Results [Nov-15-21 04:00PM]
17-05-2021	AH	4:05 PM ET (May 17)	AYTU	Aytu BioPharma, Inc.	122.53	-0.17	-0.36	-1.50	Aytu BioScience EPS misses by $1.08, misses on revenue [5/17/2021 4:19 PM]	5.42	-0.19 (-3.39%)	5.31	-0.30 (-5.33%)	5.09 - 17.00	513,415	540,000	12,210
Aytu BioScience EPS misses by $1.08, misses on revenue [5/17/2021 4:19 PM] Aytu Biopharma, Inc. to Host Earnings Call [May-17-21 02:45PM] Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights [May-17-21 04:01PM]
11-02-2021	AH		AYTU	Aytu BioScience, Inc.	148.61	-0.47	-0.50	-3.10	Aytu BioScience EPS misses by $0.28, beats on revenue [2/11/2021 4:55 PM]	8.56	-0.18 (-2.06%)	8.32	-0.42 (-4.81%)	3.35 - 29.90	504,210	660,568	24,298
Aytu BioScience EPS misses by $0.28, beats on revenue [2/11/2021 4:55 PM]
12-11-2020	AH		AYTU	Aytu BioScience, Inc.	127.10	-0.40	-0.06	-0.32	Aytu BioScience EPS beats by $0.02, beats on revenue [11/12/2020 4:35 PM]	0.9696	-0.06 (-5.86%)	0.99	-0.04 (-3.88%)	0.34 - 2.99	3,934,046	2,307,565	203,300

14-05-2020	AH		AYTU	Aytu BioScience, Inc.	156.10	-1.50	-0.39	-0.50	Aytu BioScience EPS misses by $0.10, beats on revenue [5/14/2020 4:13 PM]	1.56	-0.22 (-12.36%)	1.54	-0.02 (-1.28%)	0.34 - 2.99	17,358,070	10,579,952	455,386